Similar Papers

Paper Title
Journal
Date
Author
MiR-449b inhibits the migration and invasion of colorectal cancer cells through the negative regulation of MMP2
Ling-Li Zhang
Clinical surgery research communications | VOL. 2
Ling-Li ZhangLing-Li Zhang
25 Sep 2018
MicroRNA-769 is downregulated in colorectal cancer and inhibits cancer progression by directly targeting cyclin-dependent kinase 1
Lei Wang ... Fangfang Zhou
OncoTargets and therapy | VOL. 11
Lei Wang, et. al.Lei Wang ... Fangfang Zhou
12 Dec 2018
Silencing of linc00337 inhibits proliferation, cell cycle progression, migration, and invasion of colorectal cancer cells through the MEK/ERK pathway.
...
European review for medical and pharmacological sciences | VOL. 24
, et. al. ...
01 May 2020
Degradation of HIF-1α induced by curcumol blocks glutaminolysis and inhibits epithelial-mesenchymal transition and invasion in colorectal cancer cells.
Yong Bian ... Tiantian Liu
Cell Biology and Toxicology | VOL. 39
Yong Bian, et. al.Yong Bian ... Tiantian Liu
27 Jan 2022
View more papers

More From: Cancer letters

Paper Title
Journal
Date
Author
A Noninvasive and Highly Efficient Epigenetic Predictive Model for Efficacy of the GOLP Regimen in Patients with Intrahepatic Cholangiocarcinoma.
Xianlong Meng ... Guoming Shi
Cancer letters | VOL. -
Xianlong Meng, et. al.Xianlong Meng ... Guoming Shi
10 Jul 2025
Deglycosylated PD-L1 is a biomarker for immune checkpoint blockade response: a real-world study in breast cancer patients in Taiwan.
Shao-Chun Wang ... Mien-Chie Hung
Cancer letters | VOL. -
Shao-Chun Wang, et. al.Shao-Chun Wang ... Mien-Chie Hung
10 Jul 2025
Autophagy Paradox: Genetic and Epigenetic Control of Autophagy in Cancer Progression.
Chandra Sekhar Bhol ... Gautam Sethi
Cancer letters | VOL. -
Chandra Sekhar Bhol, et. al.Chandra Sekhar Bhol ... Gautam Sethi
09 Jul 2025
NCF2 drives tumor progression and metastasis through NR2F2/LATS2/YAP1 axis in esophageal squamous cell carcinoma.
Huan Zhang ... Ke Jiang
Cancer letters | VOL. -
Huan Zhang, et. al.Huan Zhang ... Ke Jiang
09 Jul 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.